EG20543A - Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones - Google Patents
Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolonesInfo
- Publication number
- EG20543A EG20543A EG68693A EG68693A EG20543A EG 20543 A EG20543 A EG 20543A EG 68693 A EG68693 A EG 68693A EG 68693 A EG68693 A EG 68693A EG 20543 A EG20543 A EG 20543A
- Authority
- EG
- Egypt
- Prior art keywords
- quinolones
- preparing
- novel antimicrobial
- heterosubstituted amino
- heterosubstituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Quinoline Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96896092A | 1992-10-30 | 1992-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG20543A true EG20543A (en) | 1999-07-31 |
Family
ID=25514997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG68693A EG20543A (en) | 1992-10-30 | 1993-01-30 | Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0666853A1 (en) |
| JP (1) | JPH08502750A (en) |
| KR (1) | KR950704301A (en) |
| CN (1) | CN1064357C (en) |
| AU (1) | AU687018B2 (en) |
| BR (1) | BR9307347A (en) |
| CA (1) | CA2148003A1 (en) |
| CZ (1) | CZ282581B6 (en) |
| EG (1) | EG20543A (en) |
| FI (1) | FI952049L (en) |
| HU (1) | HUT72072A (en) |
| IL (1) | IL107323A (en) |
| MX (1) | MX9306814A (en) |
| NO (1) | NO951640L (en) |
| NZ (1) | NZ257470A (en) |
| PL (1) | PL178094B1 (en) |
| RU (1) | RU2126000C1 (en) |
| SG (1) | SG59979A1 (en) |
| SK (1) | SK54795A3 (en) |
| WO (1) | WO1994010163A1 (en) |
| ZA (1) | ZA938089B (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646163A (en) * | 1992-10-30 | 1997-07-08 | The Procter & Gamble Company | Quinolone 5-(N-heterosubstituted amino) antimicrobials |
| ATE190972T1 (en) * | 1994-08-02 | 2000-04-15 | Procter & Gamble | METHOD FOR PRODUCING ANTIMICROBIAL COMPOUNDS |
| MX9700872A (en) * | 1994-08-02 | 1997-05-31 | Procter & Gamble | PROCEDURE FOR PRODUCING QUINOLONYL-LACTAM ANTIMICROBIALS AND NOVELTY INTERMEDIATE COMPOUNDS. |
| WO1997029102A1 (en) * | 1996-02-09 | 1997-08-14 | Toyama Chemical Co., Ltd. | Quinolonecarboxylic acid derivatives or salts thereof |
| RU2248199C1 (en) * | 2003-06-02 | 2005-03-20 | Открытое Акционерное Общество "Акционерное Курганское общество медицинских препаратов и изделий "Синтез" (ОАО "Синтез") | Eye drops and method for their obtaining |
| RU2265437C2 (en) * | 2003-07-02 | 2005-12-10 | Суханов Александр Владимирович | Method for treating gastric and duodenal diseases caused by helicobacter pylori |
| RU2245134C1 (en) * | 2003-09-02 | 2005-01-27 | Открытое акционерное общество "Красфарма" | Ofloxacine composition for injections |
| CA2536429C (en) | 2003-09-10 | 2012-02-14 | Kyorin Pharmaceutical Co., Ltd. | 7-(4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative |
| US8546423B2 (en) | 2005-05-18 | 2013-10-01 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
| DK1901749T3 (en) * | 2005-05-18 | 2016-10-24 | Raptor Pharmaceuticals Inc | Aerosolized fluoroquinolones AND USES THEREOF |
| EE05697B1 (en) | 2005-06-08 | 2014-02-17 | Janssen Pharmaceutica N.V. | Quinoline derivatives as antibacterial agents |
| EA010601B1 (en) * | 2005-06-09 | 2008-10-30 | Янссен Фармацевтика Н.В. | Quinoline derivatives as antibacterial agents |
| CN101020647B (en) * | 2007-02-14 | 2011-03-30 | 杭州师范学院 | Synthesis process of beta-cyclopropylamino acrylate |
| JP5363350B2 (en) * | 2007-03-19 | 2013-12-11 | 武田薬品工業株式会社 | MAPK / ERK kinase inhibitor |
| PT2214491T (en) * | 2007-10-05 | 2016-10-25 | Senhwa Biosciences Inc | Quinolone analogs and methods related thereto |
| RU2515906C2 (en) * | 2008-06-03 | 2014-05-20 | Актелион Фармасьютиклз Лтд | [4-(1-aminoethyl)cyclohexyl]methylamine and [6-(1-aminoethyl)tetrahydropyran-3-yl]methylamine derivatives |
| CN105520922A (en) | 2008-10-07 | 2016-04-27 | 拉普特制药有限公司 | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
| PT2346509T (en) | 2008-10-07 | 2020-08-05 | Horizon Orphan Llc | Inhalation of levofloxacin for reducing lung inflammation |
| AR076222A1 (en) * | 2009-04-09 | 2011-05-26 | Actelion Pharmaceuticals Ltd | DERIVATIVES 2-HYDROXIETIL-1H-QUINOLIN-ONA AND ITS AZAISOTHERAL ANALOGS WITH ANTIBACTERIAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| PT2473170T (en) | 2009-09-04 | 2019-08-23 | Horizon Orphan Llc | Use of aerosolized levofloxacin for treating cystic fibrosis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4668680A (en) * | 1985-12-12 | 1987-05-26 | Warner-Lambert Company | 5-amino-6,8-difluoroquinolones as antibacterial agents |
| JPH0228178A (en) * | 1988-04-23 | 1990-01-30 | Toyama Chem Co Ltd | Novel pyridonecarboxylic acid derivative and salt thereof |
| DE3906365A1 (en) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7- (1-PYRROLIDINYL) -3-CHINOLONE AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES, METHOD AND SUBSTITUTED (OXA) DIAZABICYCLOOCTANES AND NONANESE AS INTERMEDIATE PRODUCTS, AND ANTIBACTERIAL AGENTS AND FOOD ADDITIVES CONTAINING THEM |
| IE66202B1 (en) * | 1989-08-16 | 1995-12-13 | Pfizer | Azabicyclo quinolone carboxylic acids |
| SG47533A1 (en) * | 1990-04-18 | 1998-04-17 | Procter & Gamble Pharma | Antimicrobial quinolonyl lactams |
| ES2137942T3 (en) * | 1990-11-30 | 2000-01-01 | Warner Lambert Co | INDIVIDUAL STEREOISOMERS OF 7- (3- (AMINOALKYL) -1-PIRROLIDINYL) -QUINOLONS AND OF NAPHTIRIDONES USED AS ANTIBACTERIAL AGENTS. |
-
1993
- 1993-01-30 EG EG68693A patent/EG20543A/en active
- 1993-10-19 IL IL10732393A patent/IL107323A/en not_active IP Right Cessation
- 1993-10-22 BR BR9307347A patent/BR9307347A/en not_active Application Discontinuation
- 1993-10-22 NZ NZ257470A patent/NZ257470A/en unknown
- 1993-10-22 FI FI952049A patent/FI952049L/en unknown
- 1993-10-22 HU HU9501237A patent/HUT72072A/en unknown
- 1993-10-22 EP EP93924393A patent/EP0666853A1/en not_active Withdrawn
- 1993-10-22 KR KR1019950701690A patent/KR950704301A/en not_active Abandoned
- 1993-10-22 SK SK547-95A patent/SK54795A3/en unknown
- 1993-10-22 WO PCT/US1993/010091 patent/WO1994010163A1/en not_active Ceased
- 1993-10-22 CA CA002148003A patent/CA2148003A1/en not_active Abandoned
- 1993-10-22 SG SG1996007851A patent/SG59979A1/en unknown
- 1993-10-22 AU AU54097/94A patent/AU687018B2/en not_active Ceased
- 1993-10-22 PL PL93308671A patent/PL178094B1/en unknown
- 1993-10-22 CZ CZ951097A patent/CZ282581B6/en not_active IP Right Cessation
- 1993-10-22 RU RU95110762A patent/RU2126000C1/en active
- 1993-10-22 JP JP6511167A patent/JPH08502750A/en active Pending
- 1993-10-29 MX MX9306814A patent/MX9306814A/en not_active IP Right Cessation
- 1993-10-29 ZA ZA938089A patent/ZA938089B/en unknown
- 1993-10-30 CN CN93120224A patent/CN1064357C/en not_active Expired - Fee Related
-
1995
- 1995-04-28 NO NO951640A patent/NO951640L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO951640D0 (en) | 1995-04-28 |
| SG59979A1 (en) | 1999-02-22 |
| RU95110762A (en) | 1997-01-10 |
| PL178094B1 (en) | 2000-02-29 |
| WO1994010163A1 (en) | 1994-05-11 |
| BR9307347A (en) | 1999-05-25 |
| SK54795A3 (en) | 1995-12-06 |
| CZ109795A3 (en) | 1995-12-13 |
| KR950704301A (en) | 1995-11-17 |
| HU9501237D0 (en) | 1995-06-28 |
| PL308671A1 (en) | 1995-08-21 |
| CA2148003A1 (en) | 1994-05-11 |
| AU687018B2 (en) | 1998-02-19 |
| NZ257470A (en) | 1997-08-22 |
| MX9306814A (en) | 1994-07-29 |
| ZA938089B (en) | 1994-06-07 |
| FI952049A0 (en) | 1995-04-28 |
| JPH08502750A (en) | 1996-03-26 |
| IL107323A (en) | 2000-06-01 |
| NO951640L (en) | 1995-06-30 |
| CZ282581B6 (en) | 1997-08-13 |
| FI952049A7 (en) | 1995-04-28 |
| AU5409794A (en) | 1994-05-24 |
| EP0666853A1 (en) | 1995-08-16 |
| RU2126000C1 (en) | 1999-02-10 |
| HUT72072A (en) | 1996-03-28 |
| CN1064357C (en) | 2001-04-11 |
| CN1092773A (en) | 1994-09-28 |
| IL107323A0 (en) | 1994-01-25 |
| FI952049L (en) | 1995-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG20543A (en) | Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones | |
| HU9501973D0 (en) | Process for preparing quinoline amines | |
| SG55048A1 (en) | Process for preparing 2-para-dioxanones | |
| GB2297255B (en) | Process for preparing phencynonate hydrochloride of alpha configuration | |
| EP0514692A3 (en) | Process for the preparation of amines | |
| EP0582201A3 (en) | Process for the preparation of glycerincarbonate | |
| IL98095A0 (en) | Process for preparing peptide | |
| GB9114734D0 (en) | Process for modifying proteins | |
| HU9401695D0 (en) | Process for preparation of amines from aldehydes | |
| EP0551916A3 (en) | Process for stabilisation of proteins | |
| EP0457730A3 (en) | Process for preparation of thioderivatives of alkylhydroxyanilinotriazine | |
| EP0560109A3 (en) | Process for the preparation of 1-fluorocyclopropyl-methyl-ketone | |
| GB9323088D0 (en) | Novel process for the preparation of benzylformimidate | |
| HUT67641A (en) | Process for preparation of difluoromethoxy- and difluoromethylthioarenes | |
| EP0573874A3 (en) | Process for the preparation of beta-naphthylbenzylether | |
| EP0560127A3 (en) | Process for the preparation of cycloaliphatic amines | |
| HUT65321A (en) | Process for preparation of-n-acylated-p-phends | |
| EG20289A (en) | Process for preparing of novel pharmaceutical compositions comprising 3- substituted 2-oxindole -1- corboximides | |
| GB2275266B (en) | Process of preparing 2-methyl-3-aminobenzotrifluoride | |
| HU9303010D0 (en) | Process for preparation of 2-methyl-thiazole-5-carboxylates | |
| ZA935657B (en) | Process for the preparation of imidazypyridines | |
| HUT67910A (en) | Process for preparation of 4-alkane-aryl-benzylethers | |
| EP0422366A3 (en) | Process for the preparation of n-substituted pyrolidin-2-ones | |
| EP0547414A3 (en) | Process for the preparation of n-substituted nitro-p-phenylenediamines | |
| HUT67669A (en) | Process for preparation of chloro-methyl-pyridin derivatives |